These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7051805)

  • 41. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
    N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
    Henderson IC
    J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
    [No Abstract]   [Full Text] [Related]  

  • 43. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.
    Martín M; Ruiz A; Ruiz Borrego M; Barnadas A; González S; Calvo L; Margelí Vila M; Antón A; Rodríguez-Lescure A; Seguí-Palmer MA; Muñoz-Mateu M; Dorca Ribugent J; López-Vega JM; Jara C; Espinosa E; Mendiola Fernández C; Andrés R; Ribelles N; Plazaola A; Sánchez-Rovira P; Salvador Bofill J; Crespo C; Carabantes FJ; Servitja S; Chacón JI; Rodríguez CA; Hernando B; Álvarez I; Carrasco E; Lluch A
    J Clin Oncol; 2013 Jul; 31(20):2593-9. PubMed ID: 23733779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Follow-up adjuvant chemotherapy and chemoimmunotherapy for stage II and III carcinoma of the breast.
    Cohen E; Scanlon EF; Caprini JA; Cunningham MP; Oviedo MA; Robinson B; Knox KL
    Cancer; 1982 May; 49(9):1754-61. PubMed ID: 7042073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant therapy of breast cancer: Southwest Oncology Group studies.
    Osborne CK; Rivkin SE; McDivitt RW; Green S; Stephens RL; Costanzi JJ; O'Bryan R
    NCI Monogr; 1986; (1):71-4. PubMed ID: 3534592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease-free survival at intervals during and following completion of adjuvant chemotherapy: the NSABP experience from three breast cancer protocols.
    Fisher B; Redmond C; Wolmark N; Wieand HS
    Cancer; 1981 Sep; 48(6):1273-80. PubMed ID: 7023651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant chemotherapy for early breast cancer.
    Smith IE
    Br Med J (Clin Res Ed); 1983 Aug; 287(6389):379-80. PubMed ID: 6409315
    [No Abstract]   [Full Text] [Related]  

  • 48. A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancer.
    Cooper MR; Rhyne AL; Muss HB; Ferree C; Richards F; White DR; Stuart JJ; Jackson DV; Howard V; Shore A; Spurr CL
    Cancer; 1981 Jun; 47(12):2833-9. PubMed ID: 7020917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
    Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract]   [Full Text] [Related]  

  • 50. Adjuvant therapy in primary breast cancer.
    Wolmark N; Fisher B
    Surg Clin North Am; 1985 Feb; 65(1):161-80. PubMed ID: 3887616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
    Ludwig Breast Cancer Study Group
    Lancet; 1984 Jun; 1(8389):1256-60. PubMed ID: 6144974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure.
    Rose MA; Henderson IC; Gelman R; Boyages J; Gore SM; Come S; Silver B; Recht A; Connolly JL; Schnitt SJ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):711-7. PubMed ID: 2777660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy.
    Rabadi SJ; Haid M; Scanlon EF; Khandekar JD; Caprini JA; Oviedo MA; Cunningham MP; Grizenko KK; Cohen E
    J Surg Oncol; 1984 Aug; 26(4):233-7. PubMed ID: 6381884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials.
    Rutqvist LE; Cedermark B; Glas U; Johansson H; Rotstein S; Skoog L; Somell A; Theve T; Askergren J; Friberg S
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):629-39. PubMed ID: 2493433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast.
    Holland JF; Glidewell O; Cooper RG
    Surg Gynecol Obstet; 1980 Jun; 150(6):817-21. PubMed ID: 7376042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
    Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.
    Fowble B; Gray R; Gilchrist K; Goodman RL; Taylor S; Tormey DC
    J Clin Oncol; 1988 Jul; 6(7):1107-17. PubMed ID: 3292711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
    Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
    J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.